|
8 Aug, 2006
|
PharmaDesign and CBRC develop software to predict disorder regions in proteins. |
|
31 Mar, 2006
|
PharmaDesign, Inc. releases "PharmaGCHEM™ CKII", a structure-based focused library targeting chemokine receptor family. |
|
28 Dec, 2005
|
PharmaDesign, Inc. announced "PharmaGPEP V2S", a chemically synthesized peptide ligand candidates with one or two disulfide bonds each from the human genome information. |
|
12 Aug, 2005
|
A binding assay of PharmaGCHEM™-CK1, using a cell line expressing CCR4 showed a good result. |
|
29 June, 2005
|
PharmaDesign, Inc. releases "PharmaGCHEM™CK", a structure-based focused library targeting chemokine receptor family. |
|
03 Feb, 2005
|
PharmaDesign Inc. lincensed "PharmaGPEP™", a GPCR ligand library to Merck & Co., Inc. |
|
|
16 June, 2008
|
 Collaborative Research Agreement with AstraZeneca
|
|
6 Nov, 2006
|
PharmaDesign, Inc. releases PharmaGPEP™ ver.3SP, a peptide library designed based on bioinformatics and sequence/modification/structure information.
|
|
26 Sep, 2006
|
PharmaDesign, Inc. releases PharmaGCHEM™ DPk, a structure-based focused library targeting DAP kinases.
|
|
8 Aug, 2006
|
PharmaDesign and CBRC develop software to predict disorder regions in proteins.
|
|
5 Jan, 2006
|
PharmaDesign and Euroscreen Form Strategic Alliance for human GPCR(G protein coupled receptors) Deorphanization.
|
|
16 Nov, 2005
|
PharmaDesign, Inc. (PDI) receives an Industrial Technology Research and Development Projects grant from New Energy and Industrial Technology Development Organization for development of long peptide libraries aimed at discovery of novel drug targets.
|
|
3 Oct, 2005
|
PharmaDesign, Inc. (PDI) launches collaborative research with Pharma Valley Center (PVC) of Shizuoka Prefecture to develop anticancer drugs targeting transcription factors.
|
|
29 June, 2005
|
PharmaDesign, Inc. releases a structure-based focused library targeting chemokine receptor family.
|
|
20 April, 2005
|
PharmaDesign Inc. licenses GPCR Peptide Library to Novartis.
|
|
